Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1688832rdf:typepubmed:Citationlld:pubmed
pubmed-article:1688832lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:1688832lifeskim:mentionsumls-concept:C0003250lld:lifeskim
pubmed-article:1688832lifeskim:mentionsumls-concept:C0205419lld:lifeskim
pubmed-article:1688832lifeskim:mentionsumls-concept:C1521761lld:lifeskim
pubmed-article:1688832lifeskim:mentionsumls-concept:C0745777lld:lifeskim
pubmed-article:1688832lifeskim:mentionsumls-concept:C0591833lld:lifeskim
pubmed-article:1688832lifeskim:mentionsumls-concept:C0276037lld:lifeskim
pubmed-article:1688832pubmed:issue1lld:pubmed
pubmed-article:1688832pubmed:dateCreated1990-2-23lld:pubmed
pubmed-article:1688832pubmed:abstractTextWe describe a murine IgG1 monoclonal antibody (MAb56), specific for a cell-surface protein structure (MC56 determinant) expressed by the human CEM cell line. A large band of approximately 90 kDa was identified as the main specific component of the MC56 determinant. Such a 90-kDa protein is significantly associated with the drug-sensitive phenotype, its expression being progressively reduced quantitatively in multi-drug-resistant (MDR) variants of CEM cells, according to the extent of drug resistance. In addition, the MC56 determinant is expressed de novo in drug-sensitive revertant cell lines derived from MDR cells and unreactive with the MAb56. The MAb56 shows a high affinity towards the immunizing drug-sensitive CEM cell line (Ka = 1.86 x 10(9) L/mole) while not binding to MDR cell variants. The expression of the MC56 molecule on a variety of human cells and tissues makes such a cellular determinant a candidate as a marker for studying the MDR phenomenon both in vivo and in vitro.lld:pubmed
pubmed-article:1688832pubmed:languageenglld:pubmed
pubmed-article:1688832pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1688832pubmed:citationSubsetIMlld:pubmed
pubmed-article:1688832pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1688832pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1688832pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1688832pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1688832pubmed:statusMEDLINElld:pubmed
pubmed-article:1688832pubmed:monthJanlld:pubmed
pubmed-article:1688832pubmed:issn0020-7136lld:pubmed
pubmed-article:1688832pubmed:authorpubmed-author:MarianiMMlld:pubmed
pubmed-article:1688832pubmed:authorpubmed-author:MalavasiFFlld:pubmed
pubmed-article:1688832pubmed:authorpubmed-author:SamoggiaPPlld:pubmed
pubmed-article:1688832pubmed:authorpubmed-author:MorroneSSlld:pubmed
pubmed-article:1688832pubmed:authorpubmed-author:BarbuDDlld:pubmed
pubmed-article:1688832pubmed:authorpubmed-author:SantoniAAlld:pubmed
pubmed-article:1688832pubmed:authorpubmed-author:CianfrigliaMMlld:pubmed
pubmed-article:1688832pubmed:authorpubmed-author:CenciarelliCClld:pubmed
pubmed-article:1688832pubmed:authorpubmed-author:TombesiMMlld:pubmed
pubmed-article:1688832pubmed:authorpubmed-author:AlessioMMlld:pubmed
pubmed-article:1688832pubmed:issnTypePrintlld:pubmed
pubmed-article:1688832pubmed:day15lld:pubmed
pubmed-article:1688832pubmed:volume45lld:pubmed
pubmed-article:1688832pubmed:ownerNLMlld:pubmed
pubmed-article:1688832pubmed:authorsCompleteYlld:pubmed
pubmed-article:1688832pubmed:pagination95-103lld:pubmed
pubmed-article:1688832pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:1688832pubmed:meshHeadingpubmed-meshheading:1688832-...lld:pubmed
pubmed-article:1688832pubmed:meshHeadingpubmed-meshheading:1688832-...lld:pubmed
pubmed-article:1688832pubmed:meshHeadingpubmed-meshheading:1688832-...lld:pubmed
pubmed-article:1688832pubmed:meshHeadingpubmed-meshheading:1688832-...lld:pubmed
pubmed-article:1688832pubmed:meshHeadingpubmed-meshheading:1688832-...lld:pubmed
pubmed-article:1688832pubmed:meshHeadingpubmed-meshheading:1688832-...lld:pubmed
pubmed-article:1688832pubmed:meshHeadingpubmed-meshheading:1688832-...lld:pubmed
pubmed-article:1688832pubmed:meshHeadingpubmed-meshheading:1688832-...lld:pubmed
pubmed-article:1688832pubmed:meshHeadingpubmed-meshheading:1688832-...lld:pubmed
pubmed-article:1688832pubmed:meshHeadingpubmed-meshheading:1688832-...lld:pubmed
pubmed-article:1688832pubmed:meshHeadingpubmed-meshheading:1688832-...lld:pubmed
pubmed-article:1688832pubmed:meshHeadingpubmed-meshheading:1688832-...lld:pubmed
pubmed-article:1688832pubmed:meshHeadingpubmed-meshheading:1688832-...lld:pubmed
pubmed-article:1688832pubmed:meshHeadingpubmed-meshheading:1688832-...lld:pubmed
pubmed-article:1688832pubmed:meshHeadingpubmed-meshheading:1688832-...lld:pubmed
pubmed-article:1688832pubmed:year1990lld:pubmed
pubmed-article:1688832pubmed:articleTitleMurine monoclonal antibody recognizing a 90-kDa cell-surface determinant selectively lost by multi-drug-resistant variants of CEM cells.lld:pubmed
pubmed-article:1688832pubmed:affiliationLaboratorio di Immunologia, Istituto Superiore di Sanità, Rome, Italy.lld:pubmed
pubmed-article:1688832pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1688832pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1688832lld:pubmed